病態生化学分野
分野概要 スタッフ 研究内容 研究業績 研究室員 アルバム  
           

研究業績

≪ 前年 2009年 翌年 ≫

Books and Reviews

1) 済木育夫、山崎美佳子、松本欣三:
日本薬学会第128年会誌上シンポジウム タイ拠点大学交流事業「薬学分野:天然薬物」.
薬学雑誌, 129巻4号 387-391, 2009. [Abstract]
2) 竹野伸洋、小泉桂一、済木育夫:
総説:根拠に基づく漢方治療実践への基礎研究からのフィードバック.
日本病院薬剤師会雑誌, 45巻6号 761-765, 2009.
3) 櫻井宏明、小泉桂一、済木育夫:
漢方薬・生薬と臨床検査、トピックス:漢方の効き目を決める「証」の解析.
臨床検査, 53巻8号 950-954, 2009.

Original Papers

1) Sunghwa F., Sakurai H., Saiki I., and Koketsu M.:
Iodine-catalyzed etherification of morroniside.
Chem. Pharm. Bull., 57: 112-115, 2009. [Abstract]
2) Yasuda K., Nagakawa O., Akashi T., Fujiuti Y., Koizumi K., Saiki I., and Fuse H.:
Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer.
Prostate., 69: 346-351, 2009. [Abstract]
3) Kammasud N., Boonyarat C., Sanphanya K., Tsunoda S., Sakurai H., Saiki I., Andre I., Grierson D.S., and Vajragupt O.:
5-Substituted pyrido[2,3-d]pyrimidine, an inhibitor against three receptor tyrosine kinases.
Bioorg. Med. Chem. Lett., 19: 745-750, 2009. [Abstract]
4) Tsunoda S., Sakurai H., Saitoh Y., Ueno Y., Koizumi K., and Saiki I.:
Massive T lymphocyte infiltration into the host stroma is essential for FGF-2-promoted growth and metastasis of mammary tumors via neovascular stability.
Am. J. Pathol., 174: 671-683, 2009. [Abstract]
5) Minoda Y., Sakurai H., Kobayashi T., Yoshimura A., and Takaesu G.:
An F-box protein FBXW5 negatively regulates TAK1 MAPKKK in the IL-1β signaling pathway.
Biochem. Biophys. Res. Commun., 381: 412-417, 2009. [Abstract]
6) Cho S., Koizumi K., Takeno N., Kato S., Hashimoto I., Sakurai H., Tsukada K., and Saiki I.:
Anti-tumor effect of combining CC chemokine 22 (CCL22) and an anti-CD25 antibody on myeloma cells implanted subcutaneously into mice.
Mol. Med. Rep., 2: 773-777, 2009. [Abstract]
7) Miyanaga S., Sakurai H., Saiki I., Onaka H. and Igarashi Y.:
Synthesis and evaluation of myxochelin analogues as antimetastatic agents.
Bioorg. Med. Chem. Lett., 17: 2724-2732, 2009. [Abstract]
8) Igarashi Y., Mogi T., Yanase S., Miyanaga S., Fujita T., Sakurai H., Saiki I., and Ohsaki A.:
Brartemicin, an inhibitor of tumor cell invasion from the Actinomycete Nonomuraea sp.
J. Nat. Prod., 72: 980-982, 2009. [Abstract]
9) Shin M.S., Singhirunnusorn P., Sugishima Y., Nishimura M., Suzuki S., Koizumi K., Saiki I., and Sakurai H.:
Cross interference with TNF-α-induced TAK1 activation via EGFR-mediated p38 phosphorylation of TAK1-binding protein 1.
Biochim. Biophys. Acta, 1793: 1156-1164, 2009. [Abstract]
10) Senda, Koizumi K., Takeno N., Kato S., Yamada M., Hashimoto I., Sakurai H., Tsukada K., and Saiki I.:
Inducible capillary formation in lymphatic endothelial cells by blocking lipid phosphate phosphatase-3 activity.
Lymphat. Res. Biol., 7: 69-74, 2009. [Abstract]
11) Isono T., Kim C.J., Ando Y., Sakurai H., Okada Y., Inoue H.:
Suppression of cell invasiveness by periostin via TAB1/TAK1.
Int. J. Oncol., 35: 425-432, 2009. [Abstract]
12) Nishimura M., Shin M.S., Singhirunnusorn P., Suzuki S., Kawanishi M., Koizumi K., Saiki I., and Sakurai H.:
TAK1-mediated serine/threonine phosphorylation of epidermal growth factor receptor via p38/extracellular signal-regulated kinase: NF-κB-independent survival pathways in tumor necrosis factor alpha signaling.
Mol. Cell. Biol., 29: 5529-5539, 2009. [Abstract]
13) Zaidi S.F., Yamamoto T., Refaat A., Ahmed K., Sakurai H., Saiki I., Kondo T., Usmanghani K., Kadowaki M., and Sugiyama T.:
Modulation of activation-induced cytidine deaminase by curcumin in H. pylori-infected gastric epithelial cells.
Helicobacter, 14: 588-595, 2009. [Abstract]
14) Koizumi K., Saitoh, Y., Minami T., Tsuneyama K., Miyahara T., Nakayama T., Sakurai H., Takano Y., Nishimura M., Imai T., Yoshie O., and Saiki I.:
Role of CX3CL1/fractalkine in osteoclast differentiation and bone resorption.
J. Immunol., 183: 7825-7831, 2009. [Abstract]
15) Yamazaki K., Gohda J., Kanayama A., Miyamoto Y., Sakurai H., Yamamoto M., Akira S., Hayashi H., Su B., and Inoue J.:
Two mechanistically and temporally distinct NF-κB activation pathways in IL-1 signaling.
Sci. Signal., 2: ra66, 2009. [Abstract]

ページトップへ戻る

 
トップページ 和漢薬とがん研究の接点を求めて
富山大学和漢医薬学総合研究所 病態生化学分野
〒 930-0194 富山市杉谷2630
TEL 076-434-7620

薬学部生・大学院生募集
English
トップページ 富山大学 和漢研